SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17005294
Source:
http://linkedlifedata.com/resource/pubmed/id/17005294
Search
Subject
(
59
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0030705
,
umls-concept:C0039736
,
umls-concept:C0079083
,
umls-concept:C0123931
,
umls-concept:C0205195
,
umls-concept:C0282460
,
umls-concept:C0684249
,
umls-concept:C1517031
pubmed:issue
3
pubmed:dateCreated
2006-12-5
pubmed:grant
http://linkedlifedata.com/resource/pubmed/grant/1U01-CA-96123-01
,
http://linkedlifedata.com/resource/pubmed/grant/5R21 CA91565-02
,
http://linkedlifedata.com/resource/pubmed/grant/N01-CN-25000
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8800805
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Angiogenesis Inhibitors
,
http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Camptothecin
,
http://linkedlifedata.com/resource/pubmed/chemical/Carboplatin
,
http://linkedlifedata.com/resource/pubmed/chemical/Thalidomide
,
http://linkedlifedata.com/resource/pubmed/chemical/irinotecan
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
0169-5002
pubmed:author
pubmed-author:CrawfordJeffreyJ
,
pubmed-author:DunphyFrankF
,
pubmed-author:GarstJenniferJ
,
pubmed-author:HerndonJames EJE2nd
,
pubmed-author:KelleyMichael JMJ
,
pubmed-author:RiedelRichard FRF
pubmed:issnType
Print
pubmed:volume
54
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
431-2
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:17005294-Aged
,
pubmed-meshheading:17005294-Angiogenesis Inhibitors
,
pubmed-meshheading:17005294-Antineoplastic Agents
,
pubmed-meshheading:17005294-Antineoplastic Combined Chemotherapy Protocols
,
pubmed-meshheading:17005294-Camptothecin
,
pubmed-meshheading:17005294-Carboplatin
,
pubmed-meshheading:17005294-Carcinoma, Small Cell
,
pubmed-meshheading:17005294-Female
,
pubmed-meshheading:17005294-Humans
,
pubmed-meshheading:17005294-Lung Neoplasms
,
pubmed-meshheading:17005294-Male
,
pubmed-meshheading:17005294-Middle Aged
,
pubmed-meshheading:17005294-Thalidomide
,
pubmed-meshheading:17005294-Treatment Outcome
pubmed:year
2006
pubmed:articleTitle
Phase II study of carboplatin, irinotecan, and thalidomide combination in patients with extensive stage small-cell lung cancer.
pubmed:publicationType
Letter
,
Research Support, U.S. Gov't, Non-P.H.S.
,
Research Support, Non-U.S. Gov't
,
Clinical Trial, Phase II
,
Research Support, N.I.H., Extramural